Trading Signals: BMY Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(Bristol-Myers Squibb Company)
| BMY latest price $48.7200 (-0.41%) ($48.6700 - $49.3500) on Wed. Nov. 29, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.42% (three month average) | RSI | 31 | Latest Price | $48.7200(-0.41%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BMY advances 0.1% a day on average for past five trading days. | Weekly Trend | BMY declines -1.7% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support BMY advance at 0% a week (0% probability) IFRA(66%) SPLV(65%) XLP(63%) SDY(60%) SPY(59%) | Factors Impacting BMY price | BMY will decline at least -0.71% in a week (0% probabilities). VIXM(-34%) BNDX(-34%) VXX(-32%) KWEB(-18%) UUP(-15%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.71% (StdDev 1.42%) | Hourly BBV | -2.2 () | Intraday Trend | -0.7% | | | |
|
1 - 5 Day Possible Target | $44.59(-8.48%) | Resistance Level | $50.47 | 5 Day Moving Average | $49.17(-0.92%) | 10 Day Moving Average | $49.6(-1.77%) | 20 Day Moving Average | $50.47(-3.47%) | To recent high | -22.5% | To recent low | 0.5% | Market Cap | $109.812b | | | | Bristol-Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It includes chemically-synthesized drugs or small molecules and products produced from biological processes called biologics. The company was founded in August 1933 and is headquartered in New York, NY. |